ATP in the tumour microenvironment drives expression of nfP2X7, a key mediator of cancer cell survival
Year: 2018
Type: article
Abstract: The ATP-gated receptor P2X 7 is expressed in multiple malignant tumours including neuroblastoma, melanoma, prostate, lung and breast. P2X 7 has a significant role in mediating diverse cell responses, which upon dysregulation are associated with tumour initiation and development. The rapid, ATP-mediated activation of P2X 7 induces a fast-inward cation current in cells. However, prolonged ATP-mediated activation of P2X 7 leads to formation of a pore that increases membrane permeability and eventually causes cell death. This presents a potential paradox, as the tumour microenvironment contains extracellular ATP at levels sufficient to activate the P2X 7 pore and trigger cell death. However, P2X 7 expression is associated with enhanced cancer cell survival, proliferation and metastatic potential. At least one distinct conformational form of P2X 7 , termed non-pore functional P2X 7 (nfP2X 7 ), has been described, which is not able to form a functional pore. We demonstrate for the first time in this study that exposure to a high ATP concentration, equivalent to those measured in the tumour microenvironment, drives nfP2X 7 expression and also that nfP2X 7 is essential for tumour cell survival. We show that monoclonal antibodies raised against a P2X 7 amino acid sequence (200–216), whose conformation is distinct from that of wild-type (WT) P2X 7 , bind specifically to nfP2X 7 expressed on the surface of tumour cells. We also show that nfP2X 7 is broadly expressed in patient-derived tumour sections from a wide range of cancers. Therefore, antibodies raised against E200 provide tools that can differentiate between forms of the P2X 7 receptor that have a key role in cancer.
Source: Oncogene
Language: English
Subfield: Physiology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $5,990
Funder: Innovate UK
OpenAlex ID: W2886489703
